Showing 1 - 10 of 48
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012585624
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012589862
Persistent link: https://www.econbiz.de/10009640684
Persistent link: https://www.econbiz.de/10009640859
Corporate tax reforms carried out in EU countries since 1980 entail lower statutory tax rates and reductions in generous tax depreciation provisions. Several countries including the UK have reduced tax rates for SMEs. This study compares incentive effects of such reforms on the SMEs’...
Persistent link: https://www.econbiz.de/10005094149
We model EU countries’ bank ratings using financial variables and allowing for intercept and slope heterogeneity. Our aim is to assess whether “old” and “new” EU countries are rated differently and to determine whether “new” ones are assigned lower ratings, ceteris paribus, than...
Persistent link: https://www.econbiz.de/10008583666
Persistent link: https://www.econbiz.de/10001537258
Persistent link: https://www.econbiz.de/10001474358
Persistent link: https://www.econbiz.de/10001801040